NORTHWEST BIOTHERAPEUTICS INC Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $44.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2021-11-15
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2020-09-30 was $44.00K.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2014-09-30 was $4.43M.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2014-06-30 was $1.43M.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2014 was $1.52M.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2007 was $1.20M, a 1771.88% increase from fiscal 2006.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2006 was $64.00K, a 94.54% decline from fiscal 2005.
- NORTHWEST BIOTHERAPEUTICS INC adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2005 was $1.17M, a 1.38% increase from fiscal 2004.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2020-09-30 | $44.00K 10-Q · filed 2021-11-15 | $44.00K 10-Q · filed 2021-11-15 | ||
| 2014-12-31 | $1.52M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | $4.43M 10-Q · filed 2014-11-19 | $5.85M derived: sum of 2 quarters · filed 2014-11-19 | ||
| 2014-06-30 | $1.43M 10-Q · filed 2014-11-19 | |||
| 2007-12-31 | $1.20M 10-K · filed 2012-04-13 | |||
| 2006-12-31 | $64.00K 10-K · filed 2014-04-01 | |||
| 2005-12-31 | $1.17M 10-K · filed 2014-04-01 | |||
| 2004-12-31 | $1.16M 10-K · filed 2014-04-01 | |||
| 2003-12-31 | $114.00K 10-K · filed 2014-04-01 | |||
| 2001-12-31 | $456.00K 10-K · filed 2014-04-01 | |||
| 2000-12-31 | $1.03M 10-K · filed 2014-04-01 |